Based on previous reports by our group and others [24,25,26], we hypothesized that BECLIN-1-dependent autophagy may sensitize DLBCL patients to chemotherapy and that this outcome is correlated with BCL-2 downregulation. Here, BCL2 is linked to diffuse large B-cell lymphoma.